| __timestamp | ADMA Biologics, Inc. | Bio-Techne Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 5915545 | 357763000 |
| Thursday, January 1, 2015 | 7177633 | 452246000 |
| Friday, January 1, 2016 | 10661037 | 499023000 |
| Sunday, January 1, 2017 | 22760560 | 563003000 |
| Monday, January 1, 2018 | 16985290 | 642993000 |
| Tuesday, January 1, 2019 | 29349083 | 714006000 |
| Wednesday, January 1, 2020 | 42219783 | 738691000 |
| Friday, January 1, 2021 | 80942625 | 931032000 |
| Saturday, January 1, 2022 | 154079692 | 1105599000 |
| Sunday, January 1, 2023 | 258214999 | 1136702000 |
| Monday, January 1, 2024 | 1159060000 |
Unlocking the unknown
In the dynamic world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Bio-Techne Corporation and ADMA Biologics, Inc. have showcased contrasting trajectories. Bio-Techne, a stalwart in the industry, has consistently demonstrated robust growth, with revenues increasing by approximately 218% from 2014 to 2023. In contrast, ADMA Biologics, a rising star, has experienced a staggering 4,265% increase in the same period, highlighting its rapid expansion and potential.
While Bio-Techne's revenue reached its peak in 2023, ADMA Biologics has shown remarkable growth, especially in recent years, despite missing data for 2024. This comparison underscores the diverse strategies and market positions within the biotech sector, offering insights into the evolving landscape of innovation and competition.
Annual Revenue Comparison: Novo Nordisk A/S vs Bio-Techne Corporation
Revenue Showdown: Pfizer Inc. vs Bio-Techne Corporation
Amgen Inc. or ADMA Biologics, Inc.: Who Leads in Yearly Revenue?
Takeda Pharmaceutical Company Limited and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs ADMA Biologics, Inc.
Revenue Insights: Bio-Techne Corporation and Amneal Pharmaceuticals, Inc. Performance Compared
Breaking Down Revenue Trends: Bio-Techne Corporation vs ACADIA Pharmaceuticals Inc.
Revenue Insights: Bio-Techne Corporation and Mesoblast Limited Performance Compared
Revenue Insights: BioMarin Pharmaceutical Inc. and ADMA Biologics, Inc. Performance Compared
Breaking Down Revenue Trends: Exelixis, Inc. vs ADMA Biologics, Inc.
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Mesoblast Limited
ADMA Biologics, Inc. or MiMedx Group, Inc.: Who Leads in Yearly Revenue?